Takeda’s EDARBI ships to U.S. pharmacies
Takeda Pharmaceuticals North America Inc. has begun rolling out its hypertension medication EDARBI (azilsartan medoxomil) to U.S. pharmacies. Takeda said the angiotensin II receptor blocker has been approved by the Food and Drug Administration for the treatment of high blood pressure in adults.